Related Experiment Video
Updated: Jun 30, 2026
06:15
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Clinico-pathologic conference: persistent tachypnea in a 5-week-old boy
Rajan Wadhawan1, Pawini Khanna, Frederick Nora
1University of South Florida, College of Medicine, All Children's Hospital, St. Petersburg, Florida 33701, USA. WadhawaR@allkids.org
Fetal and Pediatric Pathology
|September 19, 2008
Summary
A 5-week-old infant presented with severe respiratory distress and tachypnea, requiring hospitalization. Despite previous treatment, symptoms persisted, indicating a complex respiratory issue in this infant.
Area of Science:
- Pediatrics
- Neonatology
- Respiratory Medicine
Background:
- A 5-week-old male infant experienced recurrent respiratory distress.
- Previous hospitalization in the pediatric intensive care unit (PICU) for similar symptoms.
Observation:
- The infant presented with tachypnea, increased work of breathing, cough, nasal flaring, and subcostal retractions.
- Home bronchodilator treatment provided no relief.
- Symptoms were present without fever, congestion, or nasal discharge.
Findings:
- Infectious workup results were negative, ruling out common infections.
- The infant required intermittent oxygen supplementation.
- Recurrent nature of symptoms suggests a chronic or complex underlying condition.
Implications:
- Further investigation is needed to determine the etiology of the infant's persistent respiratory distress.
- This case highlights the diagnostic challenges in neonates with unexplained respiratory symptoms.
- Early identification and management of underlying causes are crucial for improving outcomes in infants with recurrent respiratory issues.
Related Concept Videos
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
01:08Pneumothorax II: Pathophysiology
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: